Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDRALAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 35807.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2021, and payment made on June 02, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II